131 studies found for:    Open Studies | "Bile Duct Diseases"
Show Display Options
Rank Status Study
21 Not yet recruiting Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants
Conditions: Cholestasis;   Liver Disease
Interventions: Drug: Enteral fish oil;   Drug: Ursodeoxycholic Acid;   Drug: Placebo
22 Available SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury
Conditions: Cholestasis;   Growth Failure
Intervention: Drug: SMOFlipid
23 Recruiting B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis
Conditions: Fatigue;   Primary Biliary Cirrhosis
Interventions: Biological: Rituximab;   Other: Placebo
24 Not yet recruiting Compassionate Use of Omegaven in Children
Conditions: Total Parenteral Nutrition-induced Cholestasis;   Cholestasis;   Short Bowel Syndrome;   Gastroschisis;   Intestinal Atresia;   Infant, Premature, Diseases;   Cholestasis of Parenteral Nutrition
Intervention: Drug: Omegaven
25 Recruiting IBAT Inhibitor A4250 for Cholestatic Pruritus
Condition: Biliary Cirrhosis, Primary
Intervention: Drug: A4250
26 Not yet recruiting Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD
Condition: Cholestasis
Intervention: Drug: Intralipid 20% I.V. Fat Emulsion
27 Not yet recruiting Radiological Investigation of Bile Duct Obstruction
Condition: Gallstone Disease
Interventions: Procedure: Cholecystectomy and intraoperative cholangiography;   Procedure: Magnet resonance cholangio-pancreaticography;   Device: magnet resonance imaging;   Device: catheter
28 Recruiting Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Conditions: Liver Cancer;   Anxiety Disorder;   Depression;   Small Cell Lung Cancer;   Extrahepatic Bile Duct Cancer;   Malignant Mesothelioma;   Pancreatic Cancer;   Esophageal Cancer;   Gastric Cancer;   Non-small Cell Lung Cancer
Interventions: Behavioral: Early palliative care;   Other: No intervention
29 Recruiting Omegaven® as Parenteral Nutrition
Condition: Cholestasis
Intervention: Drug: Omegaven
30 Recruiting Phase 3 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cirrhosis
Condition: Liver Cirrhosis, Biliary
Interventions: Drug: Obeticholic Acid (OCA);   Drug: Placebo
31 Recruiting Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
Conditions: Breast Cancer;   Colon Cancer;   Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Gastrointestinal Cancer;   Liver and Intrahepatic Biliary Tract Cancer;   Lung Cancer;   Metastatic Cancer;   Pancreatic Cancer;   Rectal Cancer;   Thyroid Gland Medullary Carcinoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Procedure: radionuclide imaging;   Procedure: positron emission tomography;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Drug: Cu 64 anti-CEA monoclonal antibody M5A IV
32 Recruiting Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
Conditions: Pancreatic Neoplasms;   Cholestasis
Interventions: Drug: nab-paclitaxel;   Drug: Gemcitabine
33 Recruiting Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis
Intervention:
34 Recruiting Telomere Length and Other Parameters of Telomere Dysfunction in PSC and Colitis
Conditions: Primary Sclerosing Cholangitis;   Inflammatory Bowel Disease
Intervention:
35 Recruiting A Trial of BTT1023 in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: BTT1023
36 Recruiting Pilot Study of FFP104 Dose Escalation in PBC Subjects
Condition: Primary Biliary Cirrhosis
Intervention: Drug: FFP104
37 Recruiting Apoptosis May Have a Role in Etiopathogenesis of Obstetric Cholestasis.
Condition: Pregnancy
Intervention:
38 Recruiting Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis (PSC)
Interventions: Drug: OCA;   Drug: Placebo
39 Recruiting A Long-Term, Open-Label Study of LUM001 With a Double-Blind, Placebo Controlled, Randomized Drug Withdrawal Period to Evaluate Safety and Efficacy in Children With Alagille Syndrome
Condition: Alagille Syndrome
Interventions: Drug: LUM001;   Drug: Placebo
40 Recruiting Use of Omega 3 Oil Emulsion for Parenteral Nutrition Associated Cholestasis
Condition: Cholestasis
Intervention: Drug: Omegaven

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years